Shenzhen Historical Income Statement
| 300942 Stock | 8.48 0.50 5.57% |
Historical analysis of Shenzhen Bioeasy income statement accounts such as Interest Expense of 11.2 M, Selling General Administrative of 76.7 M or Total Revenue of 373.8 M can show how well Shenzhen Bioeasy Biotechnology performed in making a profits. Evaluating Shenzhen Bioeasy income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shenzhen Bioeasy's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Shenzhen Bioeasy Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shenzhen Bioeasy Bio is a good buy for the upcoming year.
Shenzhen |
About Shenzhen Income Statement Analysis
Shenzhen Bioeasy Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shenzhen Bioeasy shareholders. The income statement also shows Shenzhen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Shenzhen Bioeasy Income Statement Chart
Add Fundamental
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Total Revenue
Total revenue comprises all receipts Shenzhen Bioeasy Bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Shenzhen Bioeasy Bio financial statement analysis. It represents the amount of money remaining after all of Shenzhen Bioeasy Biotechnology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Shenzhen Bioeasy Biotechnology whose combined shares represent less than 50% of the total outstanding shares issued by Shenzhen Bioeasy have a minority interest in Shenzhen Bioeasy.Most accounts from Shenzhen Bioeasy's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shenzhen Bioeasy Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Bioeasy Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Shenzhen Bioeasy's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 11.2 M, whereas Selling General Administrative is forecasted to decline to about 76.7 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 5.3M | 4.1M | 10.6M | 11.2M | Tax Provision | 31.6M | 12.2M | 7.2M | 14.0M |
Shenzhen Bioeasy income statement Correlations
Click cells to compare fundamentals
Shenzhen Bioeasy Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Shenzhen Bioeasy income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 13.7M | 8.5M | 31.6M | 12.2M | 7.2M | 14.0M | |
| Interest Expense | 949.8K | 10.6M | 5.3M | 4.1M | 10.6M | 11.2M | |
| Selling General Administrative | 58.9M | 72.8M | 99.7M | 89.1M | 80.5M | 76.7M | |
| Total Revenue | 239.2M | 258.5M | 597.5M | 686.9M | 254.1M | 373.8M | |
| Gross Profit | 173.1M | 181.7M | 426.2M | 388.1M | 126.9M | 242.0M | |
| Operating Income | 105.2M | 75.1M | 268.3M | 137.7M | (66.9M) | (63.5M) | |
| Cost Of Revenue | 66.1M | 76.7M | 171.4M | 298.8M | 127.2M | 131.8M | |
| Income Before Tax | 106.0M | 73.9M | 268.0M | 94.9M | (177.8M) | (168.9M) | |
| Net Income Applicable To Common Shares | 73.9M | 92.3M | 65.4M | 236.5M | 272.0M | 285.6M | |
| Net Income | 92.3M | 65.4M | 236.5M | 83.0M | (184.9M) | (175.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Shenzhen Stock
Shenzhen Bioeasy Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shenzhen Bioeasy shareholders. The income statement also shows Shenzhen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).